{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:01:50Z","timestamp":1791352910466,"version":"4.3.1"},"reference-count":63,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1016\/j.nbd.2007.08.011","type":"journal-article","created":{"date-parts":[[2007,9,4]],"date-time":"2007-09-04T21:07:38Z","timestamp":1188940058000},"page":"161-168","source":"Crossref","is-referenced-by-count":92,"title":["Systemic administration of an mGluR5 antagonist, but not unilateral subthalamic lesion, counteracts l-DOPA-induced dyskinesias in a rodent model of Parkinson's disease"],"prefix":"10.1016","volume":"29","author":[{"given":"Giovanna","family":"Levandis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Bazzini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Th\u00e9r\u00e8se","family":"Armentero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Nappi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Blandini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2007.08.011_bib1","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.brainres.2004.11.040","article-title":"Protection but maintained dysfunction of nigral dopaminergic nerve cell bodies and striatal dopaminergic terminals in MPTP-lesioned mice after acute treatment with the mGluR5 antagonist MPEP","volume":"1033","author":"Aguirre","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2007.08.011_bib2","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/6338","article-title":"Activation of NMDA receptors reverses desensitization of mGluR5 in native and recombinant systems","volume":"2","author":"Alagarsamy","year":"1999","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2007.08.011_bib3","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0091-3057(02)00826-2","article-title":"NMDA-induced phosphorylation and regulation of mGluR5","volume":"73","author":"Alagarsamy","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.nbd.2007.08.011_bib4","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1006\/nbdi.1999.0259","article-title":"Striatal fosB expression is causally linked with l-DOPA-induced abnormal involuntary movements and the associated upregulation of striatal prodynorphin mRNA in a rat model of Parkinson's disease","volume":"6","author":"Andersson","year":"1999","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2007.08.011_bib5","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1046\/j.1460-9568.2003.02469.x","article-title":"Time course of striatal DeltaFosB-like immunoreactivity and prodynorphin mRNA levels after discontinuation of chronic dopaminomimetic treatment","volume":"17","author":"Andersson","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2007.08.011_bib6","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0022-3565(24)35047-5","article-title":"Characterization of MK-801-induced behavior as a putative rat model of psychosis","volume":"290","author":"Andine","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.nbd.2007.08.011_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2005.09.010","article-title":"Prolonged blockade of NMDA or mGluR5 glutamate receptors reduces nigrostriatal degeneration while inducing selective metabolic changes in the basal ganglia circuitry in a rodent model of Parkinson's disease","volume":"22","author":"Armentero","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2007.08.011_bib8","doi-asserted-by":"crossref","first-page":"7871","DOI":"10.1523\/JNEUROSCI.20-21-07871.2000","article-title":"Activation of metabotropic glutamate receptor 5 has direct excitatory effects and potentiates NMDA receptor currents in neurons of the subthalamic nucleus","volume":"20","author":"Awad","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2007.08.011_bib9","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/0306-4522(94)00462-E","article-title":"N-methyl-d-aspartate receptors are critical for mediating the effects of glutamate on intracellular calcium concentration and immediate early gene expression in cultured hippocampal neurons","volume":"64","author":"Bading","year":"1995","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2007.08.011_bib10","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1523\/JNEUROSCI.3831-03.2004","article-title":"Endogenous activation of mGlu5 metabotropic glutamate receptors contributes to the development of nigro-striatal damage induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice","volume":"24","author":"Battaglia","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2007.08.011_bib11","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.expneurol.2005.08.017","article-title":"Combined blockade of AMPA and NMDA glutamate receptors reduces levodopa-induced motor complications in animal models of PD","volume":"196","author":"Bibbiani","year":"2005","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2007.08.011_bib15","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0006-8993(94)01233-8","article-title":"Effect of subthalamic nucleus lesion on mitochondrial enzyme activity in rat basal ganglia","volume":"669","author":"Blandini","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2007.08.011_bib14","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1111\/j.1460-9568.1997.tb01495.x","article-title":"Subthalamic ablation reverses changes in basal ganglia oxidative metabolism and motor response to apomorphine induced by nigrostriatal lesion in rats","volume":"9","author":"Blandini","year":"1997","journal-title":"Eur. J. Neurosci."},{"issue":"2","key":"10.1016\/j.nbd.2007.08.011_bib13","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/00004647-199902000-00006","article-title":"Modifications of local cerebral metabolic rates for glucose and motor behavior in rats with unilateral lesion of the subthalamic nucleus","volume":"19","author":"Blandini","year":"1999","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.nbd.2007.08.011_bib17","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0301-0082(99)00067-2","article-title":"Functional changes of the basal ganglia circuitry in Parkinson's disease","volume":"62","author":"Blandini","year":"2000","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nbd.2007.08.011_bib16","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s100720170041","article-title":"Blockade of subthalamic glutamatergic activity corrects changes in neuronal metabolism and motor behavior in rats with nigrostriatal lesions","volume":"22","author":"Blandini","year":"2001","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.nbd.2007.08.011_bib12","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.expneurol.2004.03.005","article-title":"Neuroprotective effect of rasagiline in a rodent model of Parkinson's disease","volume":"187","author":"Blandini","year":"2004","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2007.08.011_bib18","doi-asserted-by":"crossref","first-page":"8302","DOI":"10.1523\/JNEUROSCI.23-23-08302.2003","article-title":"Metabotropic glutamate 5 receptor blockade alleviates akinesia by normalizing activity of selective basal-ganglia structures in parkinsonian rats","volume":"23","author":"Breysse","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2007.08.011_bib19","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0278-5846(01)00237-8","article-title":"Alteration of glutamate receptors in the striatum of dyskinetic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys following dopamine agonist treatment","volume":"26","author":"Calon","year":"2002","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.nbd.2007.08.011_bib21","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1471-4159.2006.04124.x","article-title":"Post- versus presynaptic plasticity in l-DOPA-induced dyskinesia","volume":"99","author":"Cenci","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2007.08.011_bib20","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1046\/j.1460-9568.1998.00285.x","article-title":"l-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin-and glutamic acid decarboxylase mRNA","volume":"10","author":"Cenci","year":"1998","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2007.08.011_bib22","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0306-4522(99)00294-8","article-title":"Changes in the regional and compartmental distribution of FosB-and JunB-like immunoreactivity induced in the dopamine-denervated rat striatum by acute or chronic l-DOPA treatment","volume":"94","author":"Cenci","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2007.08.011_bib23","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.neuroscience.2005.03.006","article-title":"Subthalamic nucleus lesion reverses motor abnormalities and striatal glutamatergic overactivity in experimental parkinsonism","volume":"133","author":"Centonze","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2007.08.011_bib24","doi-asserted-by":"crossref","first-page":"4933","DOI":"10.1523\/JNEUROSCI.17-13-04933.1997","article-title":"Chronic Fos-related antigens: stable variants of deltaFosB induced in brain by chronic treatments","volume":"17","author":"Chen","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2007.08.011_bib25","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.brainresbull.2005.12.009","article-title":"Effects of group I metabotropic glutamate receptors blockade in experimental models of Parkinson's disease","volume":"69","author":"Dekundy","year":"2006","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.nbd.2007.08.011_bib26","doi-asserted-by":"crossref","first-page":"6562","DOI":"10.1523\/JNEUROSCI.15-10-06562.1995","article-title":"Subthalamic nucleus lesions: widespread effects on changes in gene expression induced by nigrostriatal dopamine depletion in rats","volume":"15","author":"Delfs","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2007.08.011_bib27","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/jnr.20489","article-title":"Chronic treatment with the mGlu5R antagonist MPEP reduces the functional effects of the mGlu5R agonist CHPG in the striatum of 6-hydroxydopamine-lesioned rats: possible relevance to the effects of mGlu5R blockade in Parkinson's disease","volume":"80","author":"Domenici","year":"2005","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.nbd.2007.08.011_bib28","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0026-895X(24)23206-5","article-title":"Alterations in subunit expression, composition, and phosphorylation of striatal N-methyl-d-aspartate glutamate receptors in a rat 6-hydroxydopamine model of Parkinson's disease","volume":"57","author":"Dunah","year":"2000","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.nbd.2007.08.011_bib29","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1097\/00001756-199412000-00045","article-title":"NMDA receptor blockade reverses motor response alterations induced by levodopa","volume":"5","author":"Engber","year":"1994","journal-title":"NeuroReport"},{"key":"10.1016\/j.nbd.2007.08.011_bib30","doi-asserted-by":"crossref","first-page":"5042","DOI":"10.1523\/JNEUROSCI.22-12-05042.2002","article-title":"D1 dopamine receptor supersensitivity in the dopamine-depleted striatum results from a switch in the regulation of ERK1\/2\/MAP kinase","volume":"22","author":"Gerfen","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2007.08.011_bib31","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1111\/j.1460-9568.2006.05047.x","article-title":"Chronic high-frequency stimulation of the subthalamic nucleus and l-DOPA treatment in experimental parkinsonism: effects on motor behaviour and striatal glutamate transmission","volume":"24","author":"Gubellini","year":"2006","journal-title":"Eur. J. Neurosci."},{"issue":"Suppl 1","key":"10.1016\/j.nbd.2007.08.011_bib32","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.parkreldis.2004.11.005","article-title":"Pathogenesis of levodopa-induced dyskinesia: focus on D1 and D3 dopamine receptors","volume":"11","author":"Guigoni","year":"2005","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.nbd.2007.08.011_bib33","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.neuropharm.2004.11.008","article-title":"Alterations of striatal NMDA receptor subunits associated with the development of dyskinesia in the MPTP-lesioned primate model of Parkinson's disease","volume":"48","author":"Hallett","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2007.08.011_bib34","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0361-9230(97)00449-8","article-title":"Targeting the subthalamic nucleus in the treatment of Parkinson's disease","volume":"46","author":"Henderson","year":"1998","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.nbd.2007.08.011_bib35","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1046\/j.1460-9568.2000.00274.x","article-title":"Preservation of a functional nigrostriatal dopamine pathway by GDNF in the intrastriatal 6-OHDA lesion model depends on the site of administration of the trophic factor","volume":"12","author":"Kirik","year":"2000","journal-title":"Eur. J. Neurosci."},{"issue":"Suppl 14","key":"10.1016\/j.nbd.2007.08.011_bib36","doi-asserted-by":"crossref","first-page":"S290","DOI":"10.1002\/mds.20962","article-title":"Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes","volume":"21","author":"Kleiner-Fisman","year":"2006","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2007.08.011_bib37","doi-asserted-by":"crossref","first-page":"4231","DOI":"10.1523\/JNEUROSCI.16-13-04231.1996","article-title":"Amphetamine and dopamine-induced immediate early gene expression in striatal neurons depends on postsynaptic NMDA receptors and calcium","volume":"16","author":"Konradi","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2007.08.011_bib38","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.nbd.2004.07.005","article-title":"Transcriptome analysis in a rat model of l-DOPA-induced dyskinesia","volume":"17","author":"Konradi","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2007.08.011_bib39","doi-asserted-by":"crossref","first-page":"A7","DOI":"10.1038\/399a007","article-title":"The changing landscape of ischaemic brain injury mechanisms","volume":"399","author":"Lee","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2007.08.011_bib40","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1056\/NEJM199810153391603","article-title":"Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease","volume":"339","author":"Limousin","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.nbd.2007.08.011_bib41","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/0006-8993(96)00693-2","article-title":"MK-801 prevents levodopa-induced motor response alterations in parkinsonian rats","volume":"736","author":"Marin","year":"1996","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.nbd.2007.08.011_bib42","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/syn.10291","article-title":"Bilateral subthalamic nucleus lesion reverses l-DOPA-induced motor fluctuations and facilitates dyskinetic movements in hemiparkinsonian rats","volume":"51","author":"Marin","year":"2004","journal-title":"Synapse"},{"key":"10.1016\/j.nbd.2007.08.011_bib43","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1471-4159.2007.04456.x","article-title":"Antagonism of metabotropic glutamate receptor type 5 attenuates l-DOPA-induced dyskinesia and its molecular and neurochemical correlates in a rat model of Parkinson's disease","volume":"101","author":"Mela","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2007.08.011_bib44","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1001\/archneur.57.7.983","article-title":"Levodopa withdrawal after bilateral subthalamic nucleus stimulation in advanced Parkinson disease","volume":"57","author":"Molinuevo","year":"2000","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.nbd.2007.08.011_bib45","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/syn.20295","article-title":"Prevention of dyskinesia by an NMDA receptor antagonist in MPTP monkeys: effect on adenosine A2A receptors","volume":"60","author":"Morissette","year":"2006","journal-title":"Synapse"},{"key":"10.1016\/j.nbd.2007.08.011_bib46","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0006-8993(98)01191-3","article-title":"DeltaFosB: a molecular mediator of long-term neural and behavioral plasticity","volume":"835","author":"Nestler","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2007.08.011_bib47","doi-asserted-by":"crossref","first-page":"11042","DOI":"10.1073\/pnas.191352698","article-title":"DeltaFosB: a sustained molecular switch for addiction","volume":"98","author":"Nestler","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2007.08.011_bib48","first-page":"117","article-title":"Corrigendum to: enhanced tyrosine phosphorylation of striatal NMDA receptor subunits: effect of dopaminergic denervation and l-DOPA administration","volume":"820","author":"Oh","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2007.08.011_bib49","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0028-3908(01)00083-1","article-title":"Blockade of the metabotropic glutamate receptor subtype 5 (mGluR5) produces antiparkinsonian-like effects in rats","volume":"41","author":"Ossowska","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2007.08.011_bib50","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1523\/JNEUROSCI.2949-06.2007","article-title":"High-frequency stimulation of the subthalamic nucleus potentiates l-DOPA-induced neurochemical changes in the striatum in a rat model of Parkinson's disease","volume":"27","author":"Oueslati","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2007.08.011_bib52","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/ana.410390505","article-title":"Levodopa-induced dyskinesias improved by a glutamate antagonist in Parkinsonian monkeys","volume":"39","author":"Papa","year":"1996","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2007.08.011_bib51","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0006-8993(95)00924-3","article-title":"Reversal of levodopa-induced motor fluctuations in experimental parkinsonism by NMDA receptor blockade","volume":"701","author":"Papa","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2007.08.011_bib53","article-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1998"},{"key":"10.1016\/j.nbd.2007.08.011_bib54","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0014-4886(03)00363-7","article-title":"Ablation of the subthalamic nucleus protects dopaminergic phenotype but not cell survival in a rat model of Parkinson's disease","volume":"185","author":"Paul","year":"2004","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2007.08.011_bib55","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1046\/j.1460-9568.1999.00509.x","article-title":"Reaction time performance following unilateral striatal dopamine depletion and lesions of the subthalamic nucleus in the rat","volume":"11","author":"Phillips","year":"1999","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2007.08.011_bib56","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nn1040","article-title":"Loss of bidirectional striatal synaptic plasticity in l-DOPA-induced dyskinesia","volume":"6","author":"Picconi","year":"2003","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2007.08.011_bib57","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1471-4159.2004.02887.x","article-title":"Co-localization and functional interaction between adenosine A(2A) and metabotropic group 5 receptors in glutamatergic nerve terminals of the rat striatum","volume":"92","author":"Rodrigues","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2007.08.011_bib58","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0163-7258(00)00098-X","article-title":"Distribution and roles of metabotropic glutamate receptors in the basal ganglia motor circuit: implications for treatment of Parkinson's disease and related disorders","volume":"88","author":"Rouse","year":"2000","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.nbd.2007.08.011_bib59","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1111\/j.1460-9568.2006.04758.x","article-title":"l-DOPA-induced dyskinesia in adult rats with a unilateral 6-OHDA lesion of dopamine neurons is paralleled by increased c-fos gene expression in the subthalamic nucleus","volume":"23","author":"Soghomonian","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2007.08.011_bib60","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.parkreldis.2006.01.004","article-title":"Behavioural changes after bilateral subthalamic stimulation in advanced Parkinson disease: a systematic review","volume":"12","author":"Temel","year":"2006","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.nbd.2007.08.011_bib61","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s00213-005-2202-x","article-title":"Functional interaction between mGlu 5 and NMDA receptors in a rat model of Parkinson's disease","volume":"179","author":"Turle-Lorenzo","year":"2005","journal-title":"Psychopharmacology ( Berl. )"},{"key":"10.1016\/j.nbd.2007.08.011_bib62","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ejphar.2005.10.017","article-title":"Ionotropic glutamatergic neurotransmission in the ventral tegmental area modulates DeltaFosB expression in the nucleus accumbens and abstinence syndrome in morphine withdrawal rats","volume":"527","author":"Wang","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.nbd.2007.08.011_bib63","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1006\/nbdi.2002.0499","article-title":"l-DOPA-induced dyskinesia in the intrastriatal 6-hydroxydopamine model of Parkinson's disease: relation to motor and cellular parameters of nigrostriatal function","volume":"10","author":"Winkler","year":"2002","journal-title":"Neurobiol. Dis."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996107001945?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996107001945?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T20:54:13Z","timestamp":1737406453000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996107001945"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S0969996107001945"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2007.08.011","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]}}}